Cite

HARVARD Citation

    Satake, A. et al. (2020). Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T‐cell leukemia/lymphoma: A retrospective analysis. European journal of haematology. pp. 704-711. [Online]. 
  
Back to record